Curis Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.80

-0.07 (-3.74%)

As of Aug 14, 10:21 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +160.0% upside

Low Target $2.81

Average Target $4.68

High Target $5.27

Current Price $1.80

Current
$1.80

Target
$4.68

$2.81 $4.68 avg $5.27

Scenario Analysis

Bear Case

$2.81

56.1%

Low target

Base Case

$4.68

+160.0%

Avg target

Bull Case

$5.27

+192.8%

High target

Risk/Reward

3.4x

Highly favorable

Price in Context

52-Week High

$39.00

-95.4% from high

52-Week Low

$3.61

+-50.1% from low

Target vs 52W High

$4.68

-88.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%